Annual Results Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
8.26
8.26
8.26
8.26
8.26
8.26
Share Warrants & Outstandings
Total Reserve
145.14
125.19
101.65
77.98
60.49
30.93
Shareholder's Funds
153.40
133.45
109.91
86.24
68.76
39.19
Minority Interest
0.00
0.00
0.00
6.74
3.72
2.35
Long-Term Borrowings
0.18
0.45
0.30
2.81
6.05
11.55
Secured Loans
0.18
0.45
0.30
2.81
3.43
2.60
Unsecured Loans
0.00
0.00
0.00
0.00
2.62
8.96
Deferred Tax Assets / Liabilities
1.52
1.37
1.21
1.28
1.39
1.23
Other Long Term Liabilities
0.23
0.69
1.13
1.11
1.4
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1.63
1.48
1.61
1.43
1.32
1.28
Total Non-Current Liabilities
3.57
4.00
4.25
4.90
8.96
14.06
Current Liabilities
Trade Payables
5.22
3.37
5.55
4.16
3.71
4.12
Other Current Liabilities
9.97
8.93
7.77
6.05
7.11
4.97
Short Term Borrowings
1.92
6.72
6.70
6.45
8.29
11.34
Short Term Provisions
0.63
0.56
0.33
0.29
0.17
0.00
Total Current Liabilities
17.74
19.57
20.35
16.95
19.28
20.43
Total Liabilities
174.71
157.03
134.52
108.09
100.72
76.04
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
69.79
60.39
41.69
38.92
37.84
35.40
Less: Accumulated Depreciation
21.40
17.69
15.40
13.28
11.54
9.69
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
48.39
42.70
26.29
25.65
26.30
25.71
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
1.68
2.53
13.29
3.63
0.27
0.07
Intangible assets under development
0.02
0.02
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
32.77
28.19
15.41
4.03
0.00
0.00
Long Term Loans & Advances
1.01
0.97
0.96
1.04
7.69
0.60
Other Non Current Assets
2.92
0.68
0.66
0.64
0.32
0.01
Total Non-Current Assets
95.67
84.41
66.21
44.34
41.89
31.84
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
50.72
45.57
36.17
34.68
32.54
27.98
Sundry Debtors
18.82
18.66
21.01
16.36
18.10
11.86
Cash and Bank
5.56
3.29
4.86
6.81
5.45
1.86
Other Current Assets
0.49
0.54
0.51
2.87
0.12
0.10
Short Term Loans and Advances
3.45
4.56
5.75
3.03
2.62
2.40
Total Current Assets
79.04
72.62
68.31
63.76
58.83
44.20
Net Current Assets (Including Current Investments)
61.30
53.05
47.95
46.81
39.55
23.77
Total Current Assets Excluding Current Investments
79.04
72.62
68.31
63.76
58.83
44.20
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
174.71
157.03
134.52
108.09
100.72
76.04
Contingent Liabilities
7.78
12.90
6.64
1.62
0.77
0.77
Total Debt
2.10
7.17
7.00
5.80
11.94
22.89
Book Value per share (adjusted)
185.64
161.49
133
104.36
83.21
47.43
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -70.71% vs 2.43% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -66.67% vs -38.94% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 10.72% vs 14.27% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 16.25% vs 82.93% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 8.84% vs 6.31% in Mar 2024
Compare Balance Sheet Results of Titan Biotech
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.26
36.29
-28.03
-77.24%
Share Warrants & Outstandings
Total Reserve
145.14
280.70
-135.56
-48.29%
Shareholder's Funds
153.40
316.99
-163.59
-51.61%
Minority Interest
0.00
0.65
-0.65
-100.00%
Long-Term Borrowings
0.18
78.64
-78.46
-99.77%
Secured Loans
0.18
78.64
-78.46
-99.77%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
1.52
7.13
-5.61
-78.68%
Other Long Term Liabilities
0.23
2.06
-1.83
-88.83%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.63
0.96
0.67
69.79%
Total Non-Current Liabilities
3.57
88.79
-85.22
-95.98%
Current Liabilities
Trade Payables
5.22
127.63
-122.41
-95.91%
Other Current Liabilities
9.97
36.83
-26.86
-72.93%
Short Term Borrowings
1.92
205.78
-203.86
-99.07%
Short Term Provisions
0.63
2.08
-1.45
-69.71%
Total Current Liabilities
17.74
372.32
-354.58
-95.24%
Total Liabilities
174.71
778.75
-604.04
-77.57%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
69.79
435.97
-366.18
-83.99%
Less: Accumulated Depreciation
21.40
171.33
-149.93
-87.51%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
48.39
264.64
-216.25
-81.71%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.68
35.09
-33.41
-95.21%
Intangible assets under development
0.02
0.00
0.02
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
32.77
1.24
31.53
2,542.74%
Long Term Loans & Advances
1.01
7.25
-6.24
-86.07%
Other Non Current Assets
2.92
0.00
2.92
0.00%
Total Non-Current Assets
95.67
308.22
-212.55
-68.96%
Current Assets Loans & Advances
Current Investments
0.00
1.63
-1.63
-100.00%
Inventories
50.72
139.81
-89.09
-63.72%
Sundry Debtors
18.82
254.76
-235.94
-92.61%
Cash and Bank
5.56
15.15
-9.59
-63.30%
Other Current Assets
0.49
46.90
-46.41
-98.96%
Short Term Loans and Advances
3.45
12.28
-8.83
-71.91%
Total Current Assets
79.04
470.53
-391.49
-83.20%
Net Current Assets (Including Current Investments)
61.30
98.21
-36.91
-37.58%
Total Current Assets Excluding Current Investments
79.04
468.90
-389.86
-83.14%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
174.71
778.75
-604.04
-77.57%
Contingent Liabilities
7.78
43.30
-35.52
-82.03%
Total Debt
2.10
284.42
-282.32
-99.26%
Book Value per share (adjusted)
185.64
43.65
141.99
325.29%
Annual - Borrowings
Borrowings 2.10 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -70.71% vs 2.43% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -66.67% vs -38.94% in Mar 2024
Annual - Fixed Assets
Fixed Assets 50.08 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 10.72% vs 14.27% in Mar 2024
Annual - Investments
Investments 32.77 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.25% vs 82.93% in Mar 2024
Annual - Current Assets
Current Assets 79.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.84% vs 6.31% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
